Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Mather Group LLC.

Mather Group LLC. lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Get Rating) by 52.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,070 shares of the company’s stock after acquiring an additional 2,091 shares during the quarter. Mather Group LLC.’s holdings in Cardinal Health were worth $405,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Quadrature Capital Ltd acquired a new position in shares of Cardinal Health during the 3rd quarter valued at $1,732,000. Penserra Capital Management LLC acquired a new position in Cardinal Health in the 3rd quarter worth $887,000. Oppenheimer & Co. Inc. lifted its holdings in Cardinal Health by 426.8% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 19,066 shares of the company’s stock worth $996,000 after buying an additional 15,447 shares in the last quarter. Naples Global Advisors LLC lifted its holdings in Cardinal Health by 3.1% in the 3rd quarter. Naples Global Advisors LLC now owns 17,620 shares of the company’s stock worth $1,183,000 after buying an additional 535 shares in the last quarter. Finally, CoreCap Advisors LLC acquired a new position in Cardinal Health in the 2nd quarter worth $243,000. Institutional investors and hedge funds own 88.93% of the company’s stock.

Cardinal Health Stock Up 0.9 %

Shares of NYSE:CAH opened at $70.72 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $49.70 and a fifty-two week high of $81.57. The firm has a 50-day simple moving average of $76.61 and a 200 day simple moving average of $74.88. The company has a market cap of $18.22 billion, a PE ratio of 12.94, a P/E/G ratio of 1.14 and a beta of 0.76.

Cardinal Health (NYSE:CAH – Get Rating) last announced its quarterly earnings data on Thursday, February 2nd. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.13 by $0.19. Cardinal Health had a negative net margin of 0.66% and a negative return on equity of 101.28%. The business had revenue of $51.47 billion during the quarter, compared to the consensus estimate of $50.03 billion. During the same quarter in the prior year, the firm earned $1.27 EPS. The company’s revenue for the quarter was up 13.2% compared to the same quarter last year. As a group, research analysts forecast that Cardinal Health, Inc. will post 5.42 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Saturday, April 15th. Shareholders of record on Monday, April 3rd will be paid a dividend of $0.4957 per share. This represents a $1.98 dividend on an annualized basis and a yield of 2.80%. The ex-dividend date is Friday, March 31st. Cardinal Health’s payout ratio is 36.33%.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Morgan Stanley boosted their price objective on shares of Cardinal Health from $86.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, February 3rd. Credit Suisse Group boosted their price objective on shares of Cardinal Health from $89.00 to $92.00 and gave the stock a “neutral” rating in a report on Friday, February 3rd. StockNews.com upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 27th. Robert W. Baird upgraded shares of Cardinal Health from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $87.00 to $94.00 in a report on Friday, February 3rd. Finally, UBS Group boosted their target price on shares of Cardinal Health from $78.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, January 31st. Seven analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.64.

Cardinal Health Company Profile

(Get Rating)

Cardinal Health, Inc is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency.